ArticleOncotarget2018

Correction: Aptamer: A potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma.

Rusdina Bte Ladju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.